Evidence map›Paper›PMID 25796989›Full record

ArticleJournal of virological methods2015

A novel method for the measurement of hepatitis C virus infectious titres using the IncuCyte ZOOM and its application to antiviral screening.

Hazel Stewart, Christopher Bartlett, Douglas Ross-Thriepland, Joseph Shaw, Stephen Griffin, Mark Harris

Abstract read
In one paragraph

Article in Journal of virological methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Agnoprotein Is an Essential Egress Factor during BK Polyomavirus Infection.International journal of molecular sciences · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hazel StewartSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom.
Christopher BartlettSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom.
Douglas Ross-ThrieplandSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom.
Joseph ShawLeeds Institute of Cancer and Pathology, Faculty of Medicine and Health, St James's University Hospital, University of Leeds, Leeds LS9 7TF, United Kingdom.
Stephen GriffinLeeds Institute of Cancer and Pathology, Faculty of Medicine and Health, St James's University Hospital, University of Leeds, Leeds LS9 7TF, United Kingdom.
Mark HarrisSchool of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom. Electronic address: M.Harris@leeds.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/K003801/1Medical Research Council G0700124Medical Research Council MC_PC_13066Wellcome Trust 096670
6 · The paper itself

Abstract

Hepatitis C virus (HCV) is a significant human pathogen infecting 3% of the world population. An infectious molecular clone capable of replicating and releasing infectious virions in cell culture has only been available since 2005, leaving a significant knowledge gap concerning post-RNA replication events such as particle assembly, trafficking and release. Thus, a fast, efficient and accurate method of measuring infectious viral titres is highly desirable. Current methods rely upon manual counting of infected cell foci and so are both labour-intensive and susceptible to human error. Here, we report a novel protocol, which utilises the IncuCyte ZOOM instrument and related software to accurately count infected cells and extrapolation of this data to produce an infectious titre, reported as infectious units per millilitre (IU/mL). This method reduces cost, time and error in experiments. We also demonstrate that this approach is amenable to high-throughput compound screening, thereby expediting the identification of novel antivirals.

Indexed as

Antiviral AgentsCarbamatesCell Line, TumorFluorescent Antibody TechniqueGenome, ViralHepacivirusHepatitis CHumansImidazolesMicrobial Sensitivity TestsPyrrolidinesRNA, ViralSofosbuvirValineViral LoadVirus ReplicationAntiviral AgentsCarbamatesdaclatasvirImidazolesPyrrolidinesRNA, ViralSofosbuvirValineAntiviralsDiagnosisHepatitis C virusIncuCyte ZOOMTitration

Identifiers

PMID25796989
PMCPMC4411217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.